US Stock MarketDetailed Quotes

BCAX Bicara Therapeutics

Watchlist
  • 17.590
  • +0.990+5.96%
Close Dec 20 16:00 ET
  • 17.590
  • 0.0000.00%
Post 16:20 ET
957.17MMarket Cap-16.09P/E (TTM)

Bicara Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-63.54%-17.22M
-42.25%-45.63M
-8.04M
-10.53M
-32.08M
Net income from continuing operations
23.48%-17.48M
-37.36%-51.99M
---12.44M
---22.85M
---37.85M
Depreciation and amortization
650.00%15K
90.00%19K
--14K
--2K
--10K
Other non cash items
-99.49%68K
--13.5M
--113K
--13.35M
----
Change In working capital
-18.89%-1.86M
-294.46%-9.62M
--2.94M
---1.56M
--4.95M
-Change in prepaid assets
-532.00%-108K
0.87%-914K
---59K
--25K
---922K
-Change in payables and accrued expense
-6.14%-1.68M
-247.56%-8.66M
--3.04M
---1.58M
--5.87M
-Change in other current liabilities
-928.57%-72K
---47K
---40K
---7K
--0
Cash from discontinued investing activities
Operating cash flow
-63.54%-17.22M
-42.25%-45.63M
---8.04M
---10.53M
---32.08M
Investing cash flow
Cash flow from continuing investing activities
94.67%-8K
-205.21%-586K
-436K
-150K
-192K
Net PPE purchase and sale
94.67%-8K
-205.21%-586K
---436K
---150K
---192K
Cash from discontinued investing activities
Investing cash flow
94.67%-8K
-205.21%-586K
---436K
---150K
---192K
Financing cash flow
Cash flow from continuing financing activities
737.39%334.14M
759.74%272.5M
194.7M
39.9M
31.7M
Net preferred stock issuance
--0
763.63%272.35M
--194.7M
--39.82M
--31.54M
Proceeds from stock option exercised by employees
-28.57%60K
-6.88%149K
--0
--84K
--160K
Cash from discontinued financing activities
Financing cash flow
737.39%334.14M
759.74%272.5M
--194.7M
--39.9M
--31.7M
Net cash flow
Beginning cash position
1,259.94%203.86M
-12.11%4.16M
--44.21M
--14.99M
--4.73M
Current changes in cash
984.54%316.9M
39,590.75%226.28M
--186.23M
--29.22M
---573K
End cash Position
1,077.92%520.76M
5,442.09%230.44M
--230.44M
--44.21M
--4.16M
Free cash flow
-61.32%-17.23M
-43.22%-46.21M
---8.47M
---10.68M
---32.27M
Currency Unit
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -63.54%-17.22M-42.25%-45.63M-8.04M-10.53M-32.08M
Net income from continuing operations 23.48%-17.48M-37.36%-51.99M---12.44M---22.85M---37.85M
Depreciation and amortization 650.00%15K90.00%19K--14K--2K--10K
Other non cash items -99.49%68K--13.5M--113K--13.35M----
Change In working capital -18.89%-1.86M-294.46%-9.62M--2.94M---1.56M--4.95M
-Change in prepaid assets -532.00%-108K0.87%-914K---59K--25K---922K
-Change in payables and accrued expense -6.14%-1.68M-247.56%-8.66M--3.04M---1.58M--5.87M
-Change in other current liabilities -928.57%-72K---47K---40K---7K--0
Cash from discontinued investing activities
Operating cash flow -63.54%-17.22M-42.25%-45.63M---8.04M---10.53M---32.08M
Investing cash flow
Cash flow from continuing investing activities 94.67%-8K-205.21%-586K-436K-150K-192K
Net PPE purchase and sale 94.67%-8K-205.21%-586K---436K---150K---192K
Cash from discontinued investing activities
Investing cash flow 94.67%-8K-205.21%-586K---436K---150K---192K
Financing cash flow
Cash flow from continuing financing activities 737.39%334.14M759.74%272.5M194.7M39.9M31.7M
Net preferred stock issuance --0763.63%272.35M--194.7M--39.82M--31.54M
Proceeds from stock option exercised by employees -28.57%60K-6.88%149K--0--84K--160K
Cash from discontinued financing activities
Financing cash flow 737.39%334.14M759.74%272.5M--194.7M--39.9M--31.7M
Net cash flow
Beginning cash position 1,259.94%203.86M-12.11%4.16M--44.21M--14.99M--4.73M
Current changes in cash 984.54%316.9M39,590.75%226.28M--186.23M--29.22M---573K
End cash Position 1,077.92%520.76M5,442.09%230.44M--230.44M--44.21M--4.16M
Free cash flow -61.32%-17.23M-43.22%-46.21M---8.47M---10.68M---32.27M
Currency Unit USDUSDUSDUSDUSD
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.